The global market for disposable syringes anticipated to reach $13.2 billion by 2029, growing steadily at a CAGR of 6.0% over the forecast period, driven by increasing use of injectable drugs delivery devices, as well as point-of-care (POC) administration worldwide.
- Other factors driving the market growth for disposable needles/syringes include cost-effective pricing, accuracy, hygiene, ease-of-handling, and prevention of needle stick injuries.
Injections are one of the most common healthcare procedures. Every year at least 16 billion injections are administered worldwide. The vast majority of around 90% are given in curative care.
- In 2015, WHO published guideline on the use of safety-engineered syringes for intramuscular, intradermal and subcutaneous injections in healthcare settings.
- This guideline provides global, evidence-based recommendations on the use of safety-engineered injection devices to prevent the re-use of syringes and/or prevent needle-stick injuries in health care workers (HCWs).
- The ultimate aim of this guideline is to make injection practices safer for patients and HCWs, and to prevent the injection-related transmission of deadly viruses, particularly HIV, hepatitis C and hepatitis B.
- Globally, 16 billion injections are administered each year, of which 95% are for curative care. Unsafe injection practices include the reusing of syringes and needles, overuse of injections in situations where oral medications can work, and recapping of needles.
- Immunization injections account for around 5% of all injections, with the remaining covering other indications, including transfusion of blood and blood products, intravenous administration of drugs and fluids and the administration of injectable contraceptives.
- This guideline provides global, evidence-based recommendations on the use of safety-engineered injection devices to prevent the re-use of syringes and/or prevent needle-stick injuries in health care workers (HCWs).
- Re-use of injection equipment to administer injections to more than one patient, including reintroduction of injection equipment into multi-dose vials, re-use of syringe barrels or of the whole syringe, informal cleaning with re-use and other practices.
- These practices are often ingrained and believed to be safe, but in reality they lead to the transmission of bloodborne viruses such as HIV, HBV, and HCV, as well as bacterial infections and abscesses at the injection site.
- Injection practices worldwide and especially in low- and middle-income countries (LMICs) include multiple, avoidable unsafe practices that ultimately lead to the large-scale transmission of bloodborne viruses among patients, health care providers and the community at large.
- On the most recent available data, WHO estimated that, up to 1.7 million people were infected with hepatitis B virus, up to 315,000 with hepatitis C virus and as many as 33,800 with HIV through an unsafe injection.
- Injection practices worldwide and especially in low- and middle-income countries (LMICs) include multiple, avoidable unsafe practices that ultimately lead to the large-scale transmission of bloodborne viruses among patients, health care providers and the community at large.
- These practices are often ingrained and believed to be safe, but in reality they lead to the transmission of bloodborne viruses such as HIV, HBV, and HCV, as well as bacterial infections and abscesses at the injection site.
- Similarly, accidental needle-stick injuries (NSIs) in health care workers (HCWs) which occur while giving an injection or after the injection, including handling infected sharps before and after disposal.
- Certain practices considered high risk for HCWs, such as recapping contaminated needles, are associated with NSIs and have frequently been observed during surveys on injection practices.
The global disposable syringes market report provides market size estimates ($million 2019 to 2029), market share, growth trends and forecast (CAGR% 2023 to 2029).
The global market for disposable syringes segmented by product [safety syringes (automatic and manual retractable, non-retractable syringes), conventional syringes (with needles, without needles)], and geography.
- Based on the products, the safety needles and/or syringes segment accounted for more than 60% of global sales, followed by the standard or conventional disposable syringes segment.
- Reuse of needles and syringes has caused spread of diseases, especially HIV and hepatitis, among intravenous drug users. Disposable syringes commonly are used in modern medicine for the injection of drugs and vaccines or for the extraction of blood.
- Syringes are also being engineered with features to protect health workers from “needle stick” injuries and resulting infections. The new “smart” syringes WHO recommends for injections into the muscle or skin have features that prevent re-use.
- Non-reusable syringes are being used for intravenous or intramuscular injections and are fast replacing the age-old glass syringes, due to their availability in sterilized condition, ready to use, and cost-effectiveness.
- The most modern medical syringes are plastic and because they are cheap enough to dispose of after being used only once, reducing the risk of spreading blood-borne diseases.
- Plastics are finding greater use in medical disposables and replacing conventional materials like metals and glass.
- Market drivers for disposable needles/syringes include:
- Growth in the injectable drug delivery devices
- Technological advancements
- Increasing reports of needle stick injuries
- Government regulations in developed nations
The global disposable syringes market research report is further divided by geography into North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), Latin America (Brazil, Mexico, Rest of LA) and Rest of the World.
- In terms of geographical distribution, the North America region accounted for the largest share of the global market both in terms of sales and units of disposable syringes sold, followed by the Europe region.
- On the other hand, the advent of dreaded infectious diseases have added now dimension leading to rapid increased use of disposable syringes in developing countries of the emerging Asia Pacific and Latin America regions.
The report also provides the detailed market landscape and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and/or services offered, and recent trends in strategic management.
Major competitors operating in the global disposable syringes market and included in this report are B. Braun Melsungen AG, Becton, Dickinson & Company, Codan Medizinische Geräte GmbH & Co. KG, Gerresheimer AG, Medtronic plc (Covidien plc), Retractable Technologies, Inc., Smiths Medical, Inc., Star Syringe, Terumo Corporation, and Unilife Corporation.
- Product
- Safety Syringes
- Auto-disable Syringes
- Automatic Retractable Syringes
- Manually Retractable Syringes
- Non-Retractable Syringes
- Conventional Syringes
- With Needles
- Without Needles
- Safety Syringes
- Geography
- North America (U.S., Canada)
- Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
- Asia Pacific (Japan, China, India, Rest of APAC)
- Latin America (Brazil, Mexico, Rest of LA)
- Rest of the World
- Company Profiles
- B. Braun Melsungen AG
- Becton, Dickinson & Company
- Codan Medizinische Geräte GmbH & Co. KG
- Gerresheimer AG
- Medtronic plc (Covidien plc)
- Retractable Technologies, Inc.
- Smiths Medical, Inc.
- Star Syringe Ltd.
- Terumo Corporation
- Unilife Corporation
To request Table of Contents and Sample Pages of this report visit:
https://www.ihealthcareanalyst.com/report/disposable-syringes-market/
Related publications:
